Literature DB >> 219410

Effect of polymyxin B sulfate on endotoxin activity in a gram-negative septicemia model.

J J Corrigan, J F Kiernat.   

Abstract

The antiendotoxin effect of polymyxin B was investigated in experimentally induced septicemia in rabbits. The Pasteurella multocida organisms were sensitive to the antibacterial action of penicillin but not to polymyxin B. Animals pre-treated with polymyxin showed positive blood cultures and significantly reduced plasma endotoxin levels (Limulus test) with normal white blood cell and platelet counts when analyzed 6 hr after the injection of live organisms. Polymyxin therapy given after the animals had established septicemia-endotoxemia reduced the plasma endotoxin levels and improved the survival, but had no effect on the leukopenia and thrombocytopenia. The best survival data were obtained in rabbits who were treated with both penicillin and polymyxin. The data suggest that polymyxin is effective in neutralizing the endotoxic effects from live organisms and that the timing and perhaps duration of the polymyxin treatment is of critical importance. In addition, a modified Limulus lysate method was developed which showed that quantitative plasma endotoxin determination could be made more sensitive by prior heating of the plasma to remove the natural inhibitors.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 219410     DOI: 10.1203/00006450-197901000-00011

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  18 in total

1.  Binding and neutralization of bacterial lipopolysaccharide by colistin nonapeptide.

Authors:  H S Warren; S A Kania; G R Siber
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191

2.  Lactulose inhibits endotoxin induced tumour necrosis factor production by monocytes. An in vitro study.

Authors:  J W Greve; D J Gouma; P A von Leeuwen; W A Buurman
Journal:  Gut       Date:  1990-02       Impact factor: 23.059

3.  Binding and neutralization of endotoxin by Limulus antilipopolysaccharide factor.

Authors:  H S Warren; M L Glennon; N Wainwright; S F Amato; K M Black; S J Kirsch; G R Riveau; R I Whyte; W M Zapol; T J Novitsky
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

4.  Antibiotic-induced bacterial cell lysis: a therapeutic dilemma.

Authors:  J L Shenep
Journal:  Eur J Clin Microbiol       Date:  1986-02       Impact factor: 3.267

Review 5.  Clinical relevance of antibiotic-induced endotoxin release.

Authors:  J M Prins; S J van Deventer; E J Kuijper; P Speelman
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

6.  Polymyxin B sulphate protects cats against the haemodynamic and metabolic effects of E. coli endotoxin.

Authors:  B Hughes; B R Madan; J R Parratt
Journal:  Br J Pharmacol       Date:  1981-11       Impact factor: 8.739

7.  Protection against group B Neisseria meningitidis disease: effect of serogroup B polysaccharide and polymyxin B on immunogenicity of serotype protein preparations.

Authors:  M S Peppler; C E Frasch
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

8.  Purification, toxicity, and antiendotoxin activity of polymyxin B nonapeptide.

Authors:  R L Danner; K A Joiner; M Rubin; W H Patterson; N Johnson; K M Ayers; J E Parrillo
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

Review 9.  Rescuing the Last-Line Polymyxins: Achievements and Challenges.

Authors:  Sue C Nang; Mohammad A K Azad; Tony Velkov; Qi Tony Zhou; Jian Li
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

10.  Inhibition of endotoxin-induced priming of human neutrophils by lipid X and 3-Aza-lipid X.

Authors:  R L Danner; K A Joiner; J E Parrillo
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.